212 related articles for article (PubMed ID: 21245074)
1. Quantifying the economic burden of productivity loss in rheumatoid arthritis.
Filipovic I; Walker D; Forster F; Curry AS
Rheumatology (Oxford); 2011 Jun; 50(6):1083-90. PubMed ID: 21245074
[TBL] [Abstract][Full Text] [Related]
2. Critical analysis of economic tools and economic measurement applied to rheumatoid arthritis.
Her M; Kavanaugh A
Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S107-11. PubMed ID: 23078839
[TBL] [Abstract][Full Text] [Related]
3. Indirect Costs of Rheumatoid Arthritis Depending on Type of Treatment-A Systematic Literature Review.
Batko B; Rolska-Wójcik P; Władysiuk M
Int J Environ Res Public Health; 2019 Aug; 16(16):. PubMed ID: 31426543
[TBL] [Abstract][Full Text] [Related]
4. Impact of etanercept on work and activity impairment in employed moderate to severe rheumatoid arthritis patients in the United States.
Hone D; Cheng A; Watson C; Huang B; Bitman B; Huang XY; Gandra SR
Arthritis Care Res (Hoboken); 2013 Oct; 65(10):1564-72. PubMed ID: 23554320
[TBL] [Abstract][Full Text] [Related]
5. Burden of rheumatoid arthritis from a societal perspective: A prevalence-based study on cost of this illness for patients in China.
Hu H; Luan L; Yang K; Li SC
Int J Rheum Dis; 2018 Aug; 21(8):1572-1580. PubMed ID: 28211251
[TBL] [Abstract][Full Text] [Related]
6. Employer model of workplace impacts of anti-TNF therapy for rheumatoid arthritis.
Birnbaum H; Pike C; Kaufman R; Cifaldi M
J Occup Environ Med; 2009 Oct; 51(10):1167-76. PubMed ID: 19786900
[TBL] [Abstract][Full Text] [Related]
7. Economic impact of adalimumab treatment in Japanese patients with rheumatoid arthritis from the adalimumab non-interventional trial for up-verified effects and utility (ANOUVEAU) study.
Tanaka Y; Yamazaki K; Nakajima R; Komatsu S; Igarashi A; Tango T; Takeuchi T
Mod Rheumatol; 2018 Jan; 28(1):39-47. PubMed ID: 28704126
[TBL] [Abstract][Full Text] [Related]
8. Rheumatoid arthritis and work: The impact of rheumatoid arthritis on absenteeism and presenteeism.
Verstappen SM
Best Pract Res Clin Rheumatol; 2015 Jun; 29(3):495-511. PubMed ID: 26612244
[TBL] [Abstract][Full Text] [Related]
9. Productivity cost model of the treatment of rheumatoid arthritis with abatacept.
Burton WN; Morrison A; Yuan Y; Li T; Marioni RE; Maclean R
J Med Econ; 2008; 11(1):3-21. PubMed ID: 19450107
[TBL] [Abstract][Full Text] [Related]
10. The economic burden of rheumatoid arthritis: beyond health care costs.
Zhang W; Anis AH
Clin Rheumatol; 2011 Mar; 30 Suppl 1():S25-32. PubMed ID: 21360103
[TBL] [Abstract][Full Text] [Related]
11. Development of a composite questionnaire, the valuation of lost productivity, to value productivity losses: application in rheumatoid arthritis.
Zhang W; Bansback N; Boonen A; Severens JL; Anis AH
Value Health; 2012 Jan; 15(1):46-54. PubMed ID: 22264971
[TBL] [Abstract][Full Text] [Related]
12. Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era.
Hsieh PH; Wu O; Geue C; McIntosh E; McInnes IB; Siebert S
Ann Rheum Dis; 2020 Jun; 79(6):771-777. PubMed ID: 32245893
[TBL] [Abstract][Full Text] [Related]
13. Systematic review of studies of productivity loss due to rheumatoid arthritis.
Burton W; Morrison A; Maclean R; Ruderman E
Occup Med (Lond); 2006 Jan; 56(1):18-27. PubMed ID: 16286432
[TBL] [Abstract][Full Text] [Related]
14. Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis.
Gwinnutt JM; Leggett S; Lunt M; Barton A; Hyrich KL; Walker-Bone K; Verstappen SMM;
Rheumatology (Oxford); 2020 Oct; 59(10):2908-2919. PubMed ID: 32097471
[TBL] [Abstract][Full Text] [Related]
15. Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis.
Puolakka K; Kautiainen H; Mottonen T; Hannonen P; Korpela M; Hakala M; Luukkainen R; Vuori K; Blåfield H; Leirisalo-Repo M
Scand J Rheumatol; 2009; 38(2):96-103. PubMed ID: 19274516
[TBL] [Abstract][Full Text] [Related]
16. [Medical and economic aspects of rheumatoid arthritis].
Fautrel B; Gaujoux-Viala C
Bull Acad Natl Med; 2012 Oct; 196(7):1295-305; discussion 1305-6. PubMed ID: 23815015
[TBL] [Abstract][Full Text] [Related]
17. The indirect costs of arthritis resulting from unemployment, reduced performance, and occupational changes while at work.
Li X; Gignac MA; Anis AH
Med Care; 2006 Apr; 44(4):304-10. PubMed ID: 16565630
[TBL] [Abstract][Full Text] [Related]
18. Early rheumatoid arthritis 6 years after diagnosis is still associated with high direct costs and increasing loss of productivity: the Swedish TIRA project.
Hallert E; Husberg M; Kalkan A; Skogh T; Bernfort L
Scand J Rheumatol; 2014; 43(3):177-83. PubMed ID: 24354438
[TBL] [Abstract][Full Text] [Related]
19. [Productivity costs of rheumatoid arthritis in Germany. Cost composition and prediction of main cost components].
Merkesdal S; Huelsemann JL; Mittendorf T; Zeh S; Zeidler H; Ruof J
Z Rheumatol; 2006 Oct; 65(6):527-34. PubMed ID: 16534538
[TBL] [Abstract][Full Text] [Related]
20. Systematic literature review on economic implications and pharmacoeconomic issues of rheumatoid arthritis.
Furneri G; Mantovani LG; Belisari A; Mosca M; Cristiani M; Bellelli S; Cortesi PA; Turchetti G
Clin Exp Rheumatol; 2012; 30(4 Suppl 73):S72-84. PubMed ID: 23072761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
